Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Nelsen Robert
Relationship:   10% Owner
City:   Chicago
State:   IL
   
Insider Summary:
  
   
Companies Owned :   34    
Direct Shares   34,307,145    

Indirect Shares

   122,760,866      
Direct Value   $303,334,000    

Indirect Value

   $808,010,811      
Total Shares   157,068,011      
Total Value   $1,111,344,811      


Adolor Corp $0 Illumina Inc $1,396,804 Neurogesx Inc $0 Kythera Biopharmaceuticals Inc $0 Receptos, Inc. $0 Bluebird Bio, Inc. $1,655,123 Agios Pharmaceuticals Inc $3,439,653 Achaogen Inc $35,466 Sage Therapeutics, Inc. $0 VBI Vaccines Inc $1,950,354 Adesto Technologies Corp $28,547,448 Syros Pharmaceuticals, Inc. $21,379,937 Impinj Inc $206,253,979 Q32 Bio Inc $5,391,998 Denali Therapeutics Inc. $191,826 Quanterix Corp $29,393 Karuna Therapeutics, Inc. $0 Vir Biotechnology, Inc. $0 Beam Therapeutics Inc. $601,013 908 Devices Inc. $32,461,005 Sana Biotechnology, Inc. $0 Adolor Corp $0 Illumina Inc $1,396,804 Neurogesx Inc $0 Kythera Biopharmaceuticals Inc $0 Receptos, Inc. $0 Bluebird Bio, Inc. $1,655,123 Agios Pharmaceuticals Inc $3,439,653 Achaogen Inc $35,466 Sage Therapeutics, Inc. $0 VBI Vaccines Inc $1,950,354 Adesto Technologies Corp $28,547,448 Syros Pharmaceuticals, Inc. $21,379,937 Impinj Inc $206,253,979 Q32 Bio Inc $5,391,998 Denali Therapeutics Inc. $191,826 Quanterix Corp $29,393 Karuna Therapeutics, Inc. $0 Vir Biotechnology, Inc. $0 Beam Therapeutics Inc. $601,013 908 Devices Inc. $32,461,005 Sana Biotechnology, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    17   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    17   
    0    
   
     Gain/Loss Ratio :
   -17.0   
   0.0   
     Percentage Gain/Loss :
   -23.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Adolor Corp ADLR Director 2007-05-17 1,207,523 2003-12-08 402,874    Premium*  
            Illumina Inc ILMN Director 2004-02-03 11,423 2004-02-03 2,915,298    Premium*  
            Alnylam Pharmaceuticals Inc ALNY 10% Owner 0 2004-05-27 222,500    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC Director, 10% Owner 2004-03-19 0 2004-03-19 2,054,271    Premium*  
            Neurogesx Inc NGSX Director, 10% Owner 2011-07-21 4,187,777 2011-07-26 4,187,777    Premium*  
            Trubion Pharmaceuticals, Inc TRBN 10% Owner 2010-10-28 0 2010-10-28 0    Premium*  
            Kythera Biopharmaceuticals Inc KYTH Former Director 2015-03-24 10,295 2015-03-13 947,309    Premium*  
            Receptos, Inc. RCPT 10% Owner 2014-05-14 2,058,634 0    Premium*  
            Bluebird Bio, Inc. BLUE 10% Owner 2013-06-24 1,793,588 2013-06-24 0    Premium*  
            Agios Pharmaceuticals Inc AGIO Director 2017-02-28 109,230 2017-02-28 40,599    Premium*  
            Fate Therapeutics Inc FATE Director, 10% Owner 2013-10-04 0 2013-10-04 2,473,188    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 1,418,657 2014-03-17 0    Premium*  
            Sage Therapeutics, Inc. SAGE Director 2015-11-09 107,950 2015-11-09 1,124,699    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 2015-08-17 3,397,830 0    Premium*  
            Juno Therapeutics, Inc. JUNO Director 2018-03-05 0 2018-03-05 0    Premium*  
            Bellerophon Therapeutics Inc BLPH Director, 10% Owner 0 2015-02-19 965,660    Premium*  
            Pulmatrix Inc PULM Former 10% owner 2015-06-15 0 2018-04-03 3,436,456    Premium*  
            Adesto Technologies Corp IOTS 10% Owner 2015-10-30 2,276,511 2015-10-26 0    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2019-07-17 4,242,051 2016-07-06 4,637,137    Premium*  
            Impinj Inc PI 10% Owner 2016-07-26 1,366,735 2016-07-26 0    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 10% Owner 2017-08-01 0 2019-02-22 1,865,800    Premium*  
            Q32 Bio Inc QTTB 10% Owner 2019-05-21 5,768,694 2018-04-02 6,068,695    Premium*  
            Denali Therapeutics Inc. DNLI Director 2021-06-02 12,432 2021-06-02 9,668,749    Premium*  
            Quanterix Corp QTRX 10% Owner 2020-11-24 1,889 2020-11-24 1,214,770    Premium*  
            Unity Biotechnology Inc UBX Director, 10% Owner 2018-05-07 0 2018-05-07 1,682,417    Premium*  
            Twist Bioscience Corp TWST 10% Owner 2018-11-02 0 2018-11-02 954,146    Premium*  
            Karuna Therapeutics, Inc. KRTX Director, 10% Owner 2021-04-13 5,269 2021-04-13 1,456,435    Premium*  
            Vir Biotechnology, Inc. VIR Director, 10% Owner 2023-05-22 576,148 2023-05-22 12,950,556    Premium*  
            Beam Therapeutics Inc. BEAM 10% Owner 2021-06-30 28,111 2021-06-30 2,921,519    Premium*  
            908 Devices Inc. MASS 10% Owner 2020-12-22 5,725,045 2020-12-22 0    Premium*  
            Sana Biotechnology, Inc. SANA Director, 10% Owner 2024-02-08 1,353 2024-02-08 22,759,772    Premium*  
            Lyell Immunopharma, Inc. LYEL Director, 10% Owner 2021-06-21 0 2021-06-21 18,206,358    Premium*  
            Prime Medicine, Inc. PRME Director, 10% Owner 2022-10-24 0 2024-02-15 15,472,674    Premium*  
            Neumora Therapeutics, Inc. NMRA 10% Owner 2023-09-22 0 2023-11-14 4,131,207    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PRME Prime Medicine, Inc. Director   –       •       •   2024-02-15 4 B $6.25 $20,000,000 I/I 3,200,000 3,200,000 2.25 %
SANA Sana Biotechnology, Inc. Director   –       •       •   2024-02-08 4 B $5.50 $9,999,996 I/I 1,818,181 12,446,022 2.25 -
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-14 4 B $11.98 $40,217 I/I 3,357 4,131,207 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-13 4 B $11.75 $371,923 I/I 31,653 4,127,850 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-10 4 B $11.37 $198,481 I/I 17,275 4,096,197 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-09 4 B $10.53 $327,262 I/I 31,079 4,078,922 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-08 4 B $10.78 $1,017,821 I/I 92,251 4,047,843 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-07 4 B $11.50 $347,208 I/I 30,192 3,955,592 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-06 4 B $11.55 $497,597 I/I 43,082 3,925,400 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-11-03 4 B $11.38 $255,140 I/I 22,420 3,882,318 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-29 4 B $13.98 $483,149 I/I 34,560 3,859,898 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-28 4 B $13.06 $563,699 I/I 41,951 3,825,338 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-27 4 B $12.31 $301,644 I/I 24,504 3,783,387 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-26 4 B $11.73 $398,820 I/I 34,000 3,758,883 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-25 4 B $10.80 $681,464 I/I 60,740 3,724,883 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-22 4 B $11.14 $445,600 I/I 40,000 3,664,143 1.5 %
VIR Vir Biotechnology, Inc. Director   –       •       •   2023-05-22 4 A $0.00 $0 D/D 6,027 576,148 0 -
PRME Prime Medicine, Inc. Director   –       •       •   2022-10-24 4 B $17.00 $13,600,000 I/I 800,000 6,128,297 2.25 %
PRME Prime Medicine, Inc. Director   –       •       •   2022-10-24 4 A $0.00 $0 I/I 11,472,674 16,080 0 -
SANA Sana Biotechnology, Inc.   –       •       •   2022-10-05 4 A $0.00 $0 D/D 321 817 0 -
VIR Vir Biotechnology, Inc. Director   –       •       •   2022-09-06 4 A $0.00 $0 I/I 1,850 33,893 0 -
VIR Vir Biotechnology, Inc. Director   –       •       •   2022-09-06 4 A $0.00 $0 D/D 30,238 570,121 0 -
VIR Vir Biotechnology, Inc. Director   –       •       •   2022-09-06 4 D $0.00 $0 I/I (550,000) 7,290,655 0 -
VIR Vir Biotechnology, Inc. Director   –       •       •   2022-09-02 4 D $0.00 $0 I/I (450,000) 7,601,096 0 -
VIR Vir Biotechnology, Inc. Director   –       •       •   2022-09-02 4 A $0.00 $0 D/D 24,737 539,883 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us